Vitrolife Obtains Patent for Swemed Sense(TM) in Europe

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Swemed Sense™ is a unique needle that is used for the collection of oocytes in connection with IVF. The approved patent means that Vitrolife has both design protection and product patent protection for Swemed Sense™ in strategically important European markets. A patent has also been applied for in other prioritized markets.

MORE ON THIS TOPIC